Risk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants.
Polycythemia vera (PV) is a chronic myeloproliferative neoplasm characterized by an expansion of red cell mass which leads to an increased risk of thrombotic and hemorrhagic complications.
| Autores: | , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión aceptada para publicación |
| Fecha de publicación: | 2016 |
| País: | España |
| Institución: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:10230/28224 |
| Acceso en línea: | http://hdl.handle.net/10230/28224 http://dx.doi.org/10.1007/s00277-016-2783-y |
| Access Level: | acceso abierto |
| Palabra clave: | Trombosi Hemorràgia Policitèmia vera |
| Sumario: | Polycythemia vera (PV) is a chronic myeloproliferative neoplasm characterized by an expansion of red cell mass which leads to an increased risk of thrombotic and hemorrhagic complications. |
|---|